Previous 10 | Next 10 |
SAN JOSE, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the second quarter 2022 after market close on August 8, 2022. On the same day, Eargo will hos...
Medical device company Eargo ( NASDAQ: EAR ) completed the issuance of $100M senior secured convertible notes to Patient Square Capital on Jun. 28. ~$16.3M of the net proceeds was used to repay all existing third-party indebtedness and related pay-off expenses. The rem...
SAN JOSE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has completed the issuance of $100 million aggregate principal am...
Gainers: Evofem Biosciences (EVFM) +172%. Acutus Medical (AFIB) +97%. NeuroSense (NRSN) +52%. Axsome (AXSM) +42%. Clene (CLNN) +35%. AeroClean (AERC) +28%. Femasys (FEMY) +30%. Scholar Rock Holding (SRRK) +22%. Precision Bio Sciences (DTIL) +20%. Boxed (BOXD) +19%. Losers: Powerbridge Technol...
Eargo (NASDAQ:EAR) stock fell ~14% on June 27 after the company said it signed an agreement with Patient Square Capital to raise $100M via selling senior secured convertible notes, with an additional $25M, subject to conditions. Upon closing of the transaction, Patient Square will h...
Gainers: NeuroSense Therapeutics NRSN +83%. Axsome Therapeutics (AXSM) +37%. Agile Therapeutics (AGRX) +31%. GreenLight Biosciences (GRNA) +26%. Femasys (FEMY) +11%. Losers: GeoVax Labs GOVX -14%. SIGA Technologies (SIGA) -14%. Eargo (EAR) -12%. BioAtla...
SAN JOSE, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has signed a definitive agreement with Patient Square Capital ...
The following slide deck was published by Eargo, Inc. in conjunction with this event. For further details see: Eargo (EAR) presents at 42nd Annual William Blair Growth Stock Conference - Slideshow
The following slide deck was published by Eargo, Inc. in conjunction with this event. For further details see: Eargo (EAR) Investor Presentation - Slideshow
SAN JOSE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the William Blair 42 nd Annual Growth Stock Conference. Christian Gormsen,...
News, Short Squeeze, Breakout and More Instantly...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
SAN JOSE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- This quarter, Eargo, Inc. launches two new over-the-counter (OTC) hearing wellness devices, Eargo SE (launching today) and LINK by Eargo (launching in the first quarter of 2024). The new devices expand the brand’s portfolio of offerings w...
NEW YORK, NY / ACCESSWIRE / November 14, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CapStar Financial Holdings, In...